ALT logo

Altimmune, Inc. (ALT)

Profile

Full Name

Altimmune, Inc.

Ticker

NASDAQ: ALT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 26, 2017

Indexes

Not included

Website

http://altimmune.com

Employees

59

Key Details

Price

$4.32(-1.93%)

Market cap

$349.98M(Small cap)

Last Dividend

$873.01

TTM Dividend yield

-

Annual revenue

$20.00K(-95.31% YoY)

Annual EPS

-$1.34(+19.28% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $4.32
    ALT price is $4.32

    30-Day Relative Volume

    1.13
    ALT 30-day relative volume is 1.13

    Price Performance

    Price Today change

    -1.93%
    ALT price is down -1.93% today

    Price YTD change

    -40.15%
    ALT price is down -40.15% since January 1st

    Price 1-year change

    -43.82%
    ALT price is down -43.82% year-on-year

    Price 3-year change

    -65.06%
    ALT price is down -65.06% over the past 3 years

    Price Range

    Price All-time high

    $137.70
    ALT price is currently -96.87% below its historical high of $137.70

    Price 3-year low

    $2.09
    ALT price is currently +106.46% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $349.98M
    ALT market capitalization is $349.98 million

    Market cap 3-year change

    -38.89%
    ALT market capitalization is down -38.89% over the past 3 years

    Market cap All-time high

    $1.10B
    ALT market capitalization is currently -68.15% below its historical high of $1.10 billion

    Market cap sector rank

    61.07%
    ALT market capitalization is higher than 61.07% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +14.16%
    ALT shares outstanding is up +14.16% year-on-year

    Shares Outstanding 3-Year Change

    +74.9%
    ALT shares outstanding is up +74.9% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.58
    ALT beta is 1.58

    200-day SMA

    $6.43
    ALT price is currently -32.84% below its 200-day simple moving average

    50-day SMA

    $5.62
    ALT price is currently -23.18% below its 50-day simple moving average

    RSI

    41.12
    ALT 14-day relative strength index is 41.12

    Volume

    1.13
    ALT 30-day relative volume is 1.13

    ATR

    $0.58
    ALT average true range is $0.58

    10-day Historical Volatility

    305.09%
    ALT 10-day historical volatility is 305.09%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $873.01
    ALT last dividend was $873.01 per share, with an ex-dividend date of January 20, 2017

    Next Dividend

    -
    ALT next dividend has not yet been announced

    Dividend per share

    Dividend per share

    -
    ALT annual dividend per share value is unknown

    Dividend per share Sector Rank

    -
    ALT annual dividend per share is unknown

    Dividend per share 1-Year Change

    -
    ALT annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    ALT annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    -
    ALT annual dividend yield value is unknown

    Dividend yield Sector Rank

    -
    ALT annual dividend yield is unknown

    Other

    Payout ratio

    -
    ALT annual payout ratio value is unknown

    Dividends paid

    -
    ALT annual dividends paid value is unknown

    Free cash flow

    -$79.85M
    ALT annual free cash flow is -$79.85 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $20.00K
    ALT annual revenue is $20.00 thousand

    Revenue Analysts estimate

    $558.56K
    ALT annual revenue is currently -96.42% lower than the consensus analysts' forecast

    Revenue 1-year change

    -95.31%
    ALT annual revenue is down -95.31% year-on-year

    Revenue Sector rank

    2.86%
    ALT annual revenue is higher than 2.86% of companies in Healthcare sector

    EPS

    EPS

    -$1.34
    ALT annual earnings per share is -$1.34

    EPS Analysts estimate

    -$1.27
    ALT annual earnings per share is currently +5.88% higher than the consensus analysts' forecast

    EPS 1-year change

    +19.28%
    ALT annual earnings per share is up +19.28% year-on-year

    EPS Sector rank

    48.17%
    ALT annual earnings per share is higher than 48.17% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ALT annual gross profit value is unknown

    Gross margin

    -
    ALT annual gross profit margin value is unknown

    Operating profit

    -$103.17M
    ALT annual operating income is -$103.17 million

    Operating margin

    -515.86K%
    ALT annual operating profit margin is -515.86 thousand%

    Net income

    -$95.06M
    ALT annual net profit is -$95.06 million

    Net margin

    -475.30K%
    ALT annual net profit margin is -475.30 thousand%

    Expenses

    Total expenses

    $103.19M
    ALT annual total expenses is $103.19 million

    Operating expenses

    $103.19M
    ALT annual total operating expenses is $103.19 million

    Cost of goods sold

    -
    ALT annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $20.97M
    ALT annual SGA is $20.97 million

    Depreciation and amortization

    $238.00K
    ALT annual depreciation & amortization is $238.00 thousand

    Interest expense

    $9000.00
    ALT annual interest expense is $9000.00

    Income tax

    -
    ALT annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$95.05M
    ALT annual earnings before interest & taxes is -$95.05 million

    EBITDA

    -$94.81M
    ALT annual EBITDA is -$94.81 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $139.31M
    ALT annual total assets is $139.31 million

    Non current assets

    $2.05M
    ALT annual long term assets is $2.05 million

    Current assets

    $137.25M
    ALT annual total current assets is $137.25 million

    Cash and cash equivalents

    $36.93M
    ALT annual cash & cash equivalents is $36.93 million

    Accounts receivable

    $544.00K
    ALT annual accounts receivable is $544.00 thousand

    Inventory

    -
    ALT annual inventory value is unknown

    Liabilities

    Total liabilities

    $15.80M
    ALT annual total liabilities is $15.80 million

    Long term liabilities

    $5.33M
    ALT annual total long term liabilities is $5.33 million

    Current liabilities

    $10.47M
    ALT annual total current liabilities is $10.47 million

    Accounts payable

    $211.00K
    ALT annual accounts payable is $211.00 thousand

    Debt

    Total debt

    $1.68M
    ALT annual total debt is $1.68 million

    Total debt 1-year change

    +150.52%
    ALT annual total debt is up +150.52% year-on-year

    Long term debt

    $1.40M
    ALT annual long term debt is $1.40 million

    Short term debt

    $279.00K
    ALT annual short term debt is $279.00 thousand

    Equity & Capital

    Shareholders equity

    $123.51M
    ALT annual stockholders equity is $123.51 million

    Book value

    $123.51M
    ALT annual book value is $123.51 million

    Retained earnings

    -$561.39M
    ALT annual retained earnings is -$561.39 million

    Working capital

    $126.79M
    ALT annual working capital is $126.79 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$79.85M
    ALT annual cash flow from operations is -$79.85 million

    Cash from operations 1-year change

    -5.33%
    ALT annual cash flow from operations is down -5.33% year-on-year

    Cash from investing

    -$28.39M
    ALT annual cash flow from investing activities is -$28.39 million

    Cash from investing 1-year change

    -306.71%
    ALT annual cash flow from investing activities is down -306.71% year-on-year

    Cash from financing

    $10.04M
    ALT annual cash flow from financing activities is $10.04 million

    Cash from financing 1-year change

    -88.34%
    ALT annual cash flow from financing activities is down -88.34% year-on-year

    CAPEX

    CAPEX

    -
    ALT annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    ALT annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$79.85M
    ALT annual free cash flow is -$79.85 million

    Free cash flow 1-year change

    -5.26%
    ALT annual free cash flow is down -5.26% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ALT annual gross profit margin value is unknown

    Operating margin

    -515.86K%
    ALT annual operating profit margin is -515.86 thousand%

    Net margin

    -475.30K%
    ALT annual net profit margin is -475.30 thousand%

    ROA & ROE

    ROA

    -54.33%
    ALT annual return on assets is -54.33%

    ROE

    -59.86%
    ALT annual return on equity is -59.86%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ALT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ALT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.46
    ALT price to book ratio is 2.46

    PB ratio Sector rank

    62.12%
    ALT price to book ratio is higher than 62.12% of companies in Healthcare sector

    PS Ratio

    PS ratio

    17.50K
    ALT price to sales ratio is 17.50 thousand

    PS ratio Sector rank

    100%
    ALT price to sales ratio is higher than 100% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $302.46M
    ALT enterprise value is $302.46 million

    Enterprise value Sector rank

    59.17%
    ALT enterprise value is higher than 59.17% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.33
    ALT EV/EBITDA is -3.33

    EV/EBITDA Sector rank

    30.96%
    ALT EV/EBITDA is higher than 30.96% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    13.11
    ALT annual current ratio is 13.11

    Quick ratio

    -
    ALT annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    ALT annual debt to equity ratio is 0.00

    Interest coverage ratio

    -10.56K
    ALT annual interest coverage ratio is -10.56 thousand

    Risk & Stability

    Piotroski F-Score

    -
    ALT piotroski f-score value is unknown

    Altman Z-Score

    6.49
    ALT altman z-score is 6.49

    Analyst ratings

    Recent major analysts updates

    Jun 27, 25 HC Wainwright & Co.
    Buy
    Apr 3, 25 HC Wainwright & Co.
    Buy
    Apr 2, 25 Citizens Capital Markets
    Market Outperform
    Mar 14, 25 Citizens Capital Markets
    Market Outperform
    Mar 3, 25 HC Wainwright & Co.
    Buy
    Feb 28, 25 William Blair
    Market Perform
    Feb 5, 25 HC Wainwright & Co.
    Buy
    Jan 23, 25 HC Wainwright & Co.
    Buy
    Jan 22, 25 HC Wainwright & Co.
    Buy
    Jan 8, 25 Stifel
    Buy

    Institutional Ownership

    Screeners with ALT included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for Altimmune, Inc.?
    • Does Altimmune, Inc. pay dividends?
    • What sector is Altimmune, Inc. in?
    • What industry is Altimmune, Inc. in?
    • What country is Altimmune, Inc. based in?
    • When did Altimmune, Inc. go public?
    • Is Altimmune, Inc. in the S&P 500?
    • Is Altimmune, Inc. in the NASDAQ 100?
    • Is Altimmune, Inc. in the Dow Jones?
    • When was Altimmune, Inc.'s last earnings report?
    • When does Altimmune, Inc. report earnings?

    What is the ticker symbol for Altimmune, Inc.?

    The ticker symbol for Altimmune, Inc. is NASDAQ:ALT

    Does Altimmune, Inc. pay dividends?

    No, Altimmune, Inc. does not pay dividends

    What sector is Altimmune, Inc. in?

    Altimmune, Inc. is in the Healthcare sector

    What industry is Altimmune, Inc. in?

    Altimmune, Inc. is in the Biotechnology industry

    What country is Altimmune, Inc. based in?

    Altimmune, Inc. is headquartered in United States

    When did Altimmune, Inc. go public?

    Altimmune, Inc.'s initial public offering (IPO) was on May 26, 2017

    Is Altimmune, Inc. in the S&P 500?

    No, Altimmune, Inc. is not included in the S&P 500 index

    Is Altimmune, Inc. in the NASDAQ 100?

    No, Altimmune, Inc. is not included in the NASDAQ 100 index

    Is Altimmune, Inc. in the Dow Jones?

    No, Altimmune, Inc. is not included in the Dow Jones index

    When was Altimmune, Inc.'s last earnings report?

    Altimmune, Inc.'s most recent earnings report was on May 8, 2025

    When does Altimmune, Inc. report earnings?

    The next expected earnings date for Altimmune, Inc. is August 8, 2025
    On this page